Skip to main content
SpringerLink
Log in

HIV-Prä-Expositionsprophylaxe bei Männern

Die PrEP schützt — wenn sie sachgerecht eingesetzt wird

HIV Pre-Exposure prophylaxis (PrEP) in men

  • FORTBILDUNG . ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Die Prä-Expositionsprophylaxe (PrEP) bietet die Chance, gefährdete Personen gezielt vor HIV zu schützen. Die Effektivität bei Männern mit riskantem Sexualverhalten ist — gute Adhärenz und ärztliche Überwachung vorausgesetzt — gut. Die fehlende Kostenerstattung könnte sich jedoch als problematisch erweisen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Epidemiologisches Bulletin 38/2016. Epidemiologisches Bulletin 38/2016

  2. European AIDS Society Guidelines for treatment of HIV-positive adults in Europe: 8.1. European AIDS Society Guidelines for treatment of HIV-positive adults in Europe: 8.1. 8 Aufl.

  3. Grant RM, Lama JR, Anderson PL, McMahan V, u. a. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N. Engl. J. Med. 2010. 363: 2587–99

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Knox DC, Anderson PL, Harrigan PR, Tan DHS. Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis. N. Engl. J. Med. 2017. 376: 501–2

    Article  PubMed  Google Scholar 

  5. McCormack S, Dunn DT, Desai M, Dolling DI, u. a. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016. 387: 53–60

    Article  PubMed  PubMed Central  Google Scholar 

  6. Molina J-M, Capitant C, Spire B, Pialoux G, u. a. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N. Engl. J. Med. 2015. 373: 2237–46

    Article  CAS  PubMed  Google Scholar 

  7. Molina JM, Capitant C, Charreau I, et al. On demand PrEP with oral TDF/FTC in MSM: results of the ANRS Ipergay trial. Program and abstracts of the 2015 Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington. Abstract 23LB. Molina JM, Capitant C, Charreau I, et al. On demand PrEP with oral TDF/FTC in MSM: results of the ANRS Ipergay trial. Program and abstracts of the 2015 Conference on Retroviruses and Opportunistic Infections; February 23-26, 2015; Seattle, Washington. Abstract 23LB.

  8. Spinner CD, Boesecke C, Zink A, Jessen H, u. a. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection 2015;, S. 1–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin II, Klinikum rechts der Isar, Ismaninger Str. 22, D-81675, München, Deutschland

    Christoph D. Spinner

Authors
  1. Christoph D. Spinner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph D. Spinner.

Additional information

This article is part of a supplement not sponsored by the industry.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spinner, C.D. Die PrEP schützt — wenn sie sachgerecht eingesetzt wird. MMW - Fortschritte der Medizin 159 (Suppl 2), 40–42 (2017). https://doi.org/10.1007/s15006-017-9735-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-017-9735-x

Keywords

Search

Navigation